0001127602-24-001436.txt : 20240117
0001127602-24-001436.hdr.sgml : 20240117
20240117163841
ACCESSION NUMBER: 0001127602-24-001436
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240116
FILED AS OF DATE: 20240117
DATE AS OF CHANGE: 20240117
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Watson David O.
CENTRAL INDEX KEY: 0001657719
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38276
FILM NUMBER: 24538934
MAIL ADDRESS:
STREET 1: 6400 WESTWIND WAY
STREET 2: SUITE A
CITY: CRESTWOOD
STATE: KY
ZIP: 40014
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Apellis Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001492422
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 271537290
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 FIFTH AVENUE
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 617-977-5700
MAIL ADDRESS:
STREET 1: 100 FIFTH AVENUE
CITY: WALTHAM
STATE: MA
ZIP: 02451
4
1
form4.xml
PRIMARY DOCUMENT
X0508
4
2024-01-16
0001492422
Apellis Pharmaceuticals, Inc.
APLS
0001657719
Watson David O.
C/O APELLIS PHARMACEUTICALS, INC
100 FIFTH AVENUE, 3RD FLOOR
WALTHAM
MA
02451
1
General Counsel
0
Common Stock
2024-01-16
4
A
0
23748
0
A
113501
D
Common Stock
2024-01-16
4
S
0
4240
66.8086
D
109261
D
Common Stock
3333
I
Indirect Owner (Custodial Account for Son)
Common Stock
80705
I
Indirect Owner (The David O. Watson Irrevocable Trust of 2023)
Common Stock
6667
I
Indirect Owner (The Watson Education Trust)
Stock Option (Right to Buy)
66.30
2024-01-16
4
A
0
34533
66.30
A
2034-01-15
Common Stock
34533
34533
D
This represents an award of Restricted Stock Units granted 01/16/2024 that vests annually from grant date over a four year period subject to continued service.
This represents shares sold to cover tax withholding on the Restricted Stock Units released on 01/12/2024.
This represents a custodial account held by the reporting person for the sole benefit of his minor son.
The securities are held by The David O. Watson Irrevocable Trust of 2023. William Zorn is the trustee of The David O. Watson Irrevocable Trust of 2023. The reporting person disclaims beneficial ownership over the shares held by The David O. Watson Irrevocable Trust of 2023 except to the extent of his pecuniary interest therein.
The securities are held by The Watson Education Trust (the "Trust"), for which the reporting person serves as trustee. The reporting person disclaims beneficial ownership over the shares held by the Trust except to the extent of his pecuniary interest therein.
This represents a stock option award granted 01/16/2024 that vests over a four year period. 25% vests one year from grant date and the remaining 75% vests monthly thereafter subject to continued service.
David Watson
2024-01-17